Fullerton deal is no side gig for Japan Inc
Mitsubishi’s latest investment in Singapore’s Fullerton Health underscores how Japan Inc has been swooping in on healthcare assets across South-east Asia and reshaping the sector – block by block
“WHERE there’s a will, there’s a way” could well sum up Japan Inc’s quiet but profound pivot into South-east Asia’s lucrative private healthcare space, where demand outruns capacity.
When Sumitomo – the Japanese conglomerate – swooped in to acquire Malaysia’s CareClinics Healthcare Services in 2020, the climate was unforgiving. The deal was sealed at the height of the pandemic with travel and movement curbs turning negotiations and integration issues into a logistical nightmare.
But it paid off. Four years later, Sumitomo has grown that small foothold into the country’s largest private clinic network with over 100 clinics; it plans to triple this by 2026.
TRENDING NOW
When every phone becomes a satellite phone, what happens to Asia’s telcos?
Koh Brothers Eco Engineering faces up to S$57.6 million in potential legal liabilities
Father-and-son duo Raj Kumar and Kishin in exclusive due diligence to buy Scotts Square
Anytime Fitness Asia’s owner said to weigh US$400 million sale